Skip to main content
. Author manuscript; available in PMC: 2017 Jun 19.
Published in final edited form as: Oncogene. 2016 Dec 19;36(23):3263–3273. doi: 10.1038/onc.2016.471

Figure 1. Spontaneous relapse after suppression of Ras oncogene expression in mice with NRAS(V12)-driven AML.

Figure 1

White blood cell (WBC) counts of leukemic SCID Beige mice with NRAS(V12)-dependent (NRD) AML rapidly decline after doxycycline (Dox)-mediated suppression of NRAS(V12) expression. Two of 5 mice spontaneously relapsed with NRAS(V12)-independent AML (NRI1 and NRI1 AMLs) despite continued Dox treatment.